AzTrials
AzTrials

Deprivation AmblyopiaNCT04217772

OCTA Analysis In Children After Lensectomy

A study testing Optical Coherence Tomography Angiography in people with Deprivation Amblyopia, run by Wenzhou Medical University at 2 sites in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to quantify and compare the foveal avascular zone (FAZ), the parafoveal and foveal vessel density of superficial (SCP) and deep capillary plexus (DCP) and retinal thickness in deprivation amblyopic eyes, fellow non-amblyopic eyes, and age-matched normal eyes, using optical coherence tomography… Read more about this study

Who is it for?
Ages 3 to 18 yearsHealthy volunteers can take part
Conditions the study is for
Deprivation Amblyopia
What is being tested?
Optical Coherence Tomography Angiography
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
2 sitesChina
Study dates
1 Dec 2017to 1 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • children after cataract surgery and healthy volunteers

Who cannot join

  • presence of corneal opacity preventing detailed imaging
  • nystagmus
  • retinal disease,
  • persistent fetal vasculature
  • intraocular inflammation,
  • glaucoma
Show all 10Show fewer
  • vitreoretinal surgery
  • premature birth
  • neurologic disease
  • systemic disease that could alter microvasculature (including diabetes, hypertension, cardiovascular disease and renal disease)

Trial locations and contacts

2 sites in 1 country.

China2 sites, 2 recruiting
  • Eye Hospital of WMU

    Hangzhou, Zhejiang, 325027

    Yune Zhao, +8613968832833, zyehzeye@126.com

    Recruiting
  • The affiliated Eye Hospital of Wenzhou Medical College

    Wenzhou, Zhejiang, 325027

    Recruiting

Other trials in China

About this study

Official title: Optical Coherence Tomography Angiography Analysis After Childhood Lensectomy

The aim of this study is to quantify and compare the foveal avascular zone (FAZ), the parafoveal and foveal vessel density of superficial (SCP) and deep capillary plexus (DCP) and retinal thickness in deprivation amblyopic eyes, fellow non-amblyopic eyes, and age-matched normal eyes, using optical coherence tomography angiography (OCTA). The FAZ, parafoveal and foveal SCP and DCP, and retinal thickness were measured in normal controls and at least 3 months postoperatively in children with unilateral cataract and compared between groups after adjusting for axial length and spherical equivalents.

Being tested
Optical Coherence Tomography Angiography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Optical Coherence Tomography AngiographyDevice

    A device testing the vascular density in the retina

Study groups in NCT04217772
Study groupRoleWhat they receive
Eyes post-lensectomyExperimentalEyes of children after cataract surgery
Receives: Device: Optical Coherence Tomography Angiography
Healthy EyesNo interventionEyes of healthy volunteers

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Foveal retinal thickness

    Foveal retinal thickness in microns

    Measured: up to 36 months

  2. Area of foveal avascular zone

    Area of foveal avascular zone in square microns

    Measured: up to 36 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jan 2020
  2. Study start1 Dec 2017
  3. Primary completion1 Dec 2020 (estimated)
  4. Study completion1 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04217772
Sponsor's protocol ID
OCTA-LZL
Status last verified
Jan 2020
First submitted
29 Dec 2019
Last updated
3 Jan 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Optical Coherence Tomography Angiography in people with Deprivation Amblyopia, run by Wenzhou Medical University at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Zhangliang Li, MD (+8613968832833, lizhangliang0328@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Foveal retinal thickness (time frame: up to 36 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in